Rob Striker

5.0k total citations
66 papers, 2.3k citations indexed

About

Rob Striker is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Rob Striker has authored 66 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Epidemiology and 18 papers in Infectious Diseases. Recurrent topics in Rob Striker's work include Hepatitis C virus research (12 papers), Colorectal and Anal Carcinomas (10 papers) and HIV Research and Treatment (10 papers). Rob Striker is often cited by papers focused on Hepatitis C virus research (12 papers), Colorectal and Anal Carcinomas (10 papers) and HIV Research and Treatment (10 papers). Rob Striker collaborates with scholars based in United States, Sweden and Ethiopia. Rob Striker's co-authors include Scott J. Hultgren, Françoise Jacob‐Dubuisson, Allison Bearden, Joseph A. McBride, Israr-ul H. Ansari, Karen Dodson, Julie A. Keating, Dipankar Bhattacharya, Fiona Fernandes and Spencer Hoover and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Rob Striker

62 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob Striker United States 26 721 599 563 363 340 66 2.3k
Karen Kristine Sørensen Norway 26 688 1.0× 480 0.8× 680 1.2× 156 0.4× 483 1.4× 57 2.6k
Ralf Altmeyer France 31 934 1.3× 2.0k 3.3× 778 1.4× 164 0.5× 272 0.8× 58 3.8k
Ursula Wiedermann Austria 38 814 1.1× 767 1.3× 478 0.8× 141 0.4× 115 0.3× 192 4.4k
Lester M. Shulman Israel 36 1.0k 1.4× 1.9k 3.2× 553 1.0× 298 0.8× 165 0.5× 121 4.1k
Daniel C. Pevear United States 30 813 1.1× 1.1k 1.8× 1.4k 2.4× 214 0.6× 95 0.3× 63 3.5k
Ho‐Joon Shin South Korea 25 964 1.3× 467 0.8× 363 0.6× 65 0.2× 127 0.4× 108 2.0k
Gary P. Wang United States 22 1.7k 2.4× 880 1.5× 573 1.0× 728 2.0× 149 0.4× 48 3.0k
Arndt Benecke France 31 1.7k 2.4× 910 1.5× 471 0.8× 523 1.4× 60 0.2× 85 4.0k
Brian C. Keller United States 18 1.5k 2.0× 1.1k 1.9× 643 1.1× 411 1.1× 224 0.7× 48 3.4k
Judith M. Ball United States 27 798 1.1× 1.7k 2.8× 416 0.7× 468 1.3× 143 0.4× 50 2.9k

Countries citing papers authored by Rob Striker

Since Specialization
Citations

This map shows the geographic impact of Rob Striker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Striker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Striker more than expected).

Fields of papers citing papers by Rob Striker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Striker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Striker. The network helps show where Rob Striker may publish in the future.

Co-authorship network of co-authors of Rob Striker

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Striker. A scholar is included among the top collaborators of Rob Striker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Striker. Rob Striker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moran, Michael, et al.. (2025). Fatal toxoplasmic encephalitis triggered by anti-TNF therapy. Heliyon. 11(3). e41965–e41965.
3.
Striker, Rob, et al.. (2023). A Qualitative Study of Barriers to Anal Cancer Screenings in US Veterans Living with HIV. AIDS Patient Care and STDs. 37(9). 436–446. 6 indexed citations
4.
Ayuso, José M., Marı́a Virumbrales-Muñoz, Cristina Sánchez‐de‐Diego, et al.. (2023). Microphysiological model reveals the promise of memory-like natural killer cell immunotherapy for HIV± cancer. Nature Communications. 14(1). 6681–6681. 9 indexed citations
6.
Yang, Qiuyu, et al.. (2022). Do immune inflammatory markers correlate with anal dysplasia and anal cancer risk in patients living with HIV?. International Journal of Colorectal Disease. 37(5). 983–988. 3 indexed citations
7.
Wlodarchak, Nathan, et al.. (2021). Engineering Selectivity for Reduced Toxicity of Bacterial Kinase Inhibitors Using Structure-Guided Medicinal Chemistry. ACS Medicinal Chemistry Letters. 12(2). 228–235. 5 indexed citations
8.
9.
Schaenzer, Adam J., Nathan Wlodarchak, David H. Drewry, et al.. (2018). GW779439X and Its Pyrazolopyridazine Derivatives Inhibit the Serine/Threonine Kinase Stk1 and Act As Antibiotic Adjuvants against β-Lactam-Resistant Staphylococcus aureus. ACS Infectious Diseases. 4(10). 1508–1518. 26 indexed citations
10.
Wlodarchak, Nathan, Adam J. Schaenzer, Kenneth A. Satyshur, et al.. (2018). In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth. Molecular Pharmaceutics. 15(11). 5410–5426. 22 indexed citations
11.
Berry, Scott M., et al.. (2017). RNA-mediated TILDA for improved cell capacity and enhanced detection of multiply-spliced HIV RNA. Integrative Biology. 9(11). 876–884. 6 indexed citations
12.
McBride, Joseph A. & Rob Striker. (2017). Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health?. PLoS Pathogens. 13(11). e1006624–e1006624. 170 indexed citations
13.
Pensinger, Daniel A., Grischa Y. Chen, William J. B. Vincent, et al.. (2016). The Listeria monocytogenes PASTA Kinase PrkA and Its Substrate YvcK Are Required for Cell Wall Homeostasis, Metabolism, and Virulence. PLoS Pathogens. 12(11). e1006001–e1006001. 49 indexed citations
14.
Striker, Rob & Andrew Mehle. (2014). Inhibitors of Peptidyl Proline Isomerases As Antivirals in Hepatitis C and Other Viruses. PLoS Pathogens. 10(11). e1004428–e1004428. 1 indexed citations
15.
Ansari, Israr-ul H., Todd M. Allen, Andrew Berical, et al.. (2013). Phenotypic analysis of NS5A variant from liver transplant patient with increased cyclosporine susceptibility. Virology. 436(2). 268–273. 6 indexed citations
16.
Keating, Julie A., Dipankar Bhattacharya, Samuel S. C. Rund, et al.. (2013). Mosquito Protein Kinase G Phosphorylates Flavivirus NS5 and Alters Flight Behavior in Aedes aegypti and Anopheles gambiae. Vector-Borne and Zoonotic Diseases. 13(8). 590–600. 21 indexed citations
17.
Huprikar, Shirish, Elizabeth Bosserman, Gopi Patel, et al.. (2013). Donor-Derived Trypanosoma cruzi Infection in Solid Organ Recipients in the United States, 2001–2011. American Journal of Transplantation. 13(9). 2418–2425. 69 indexed citations
18.
Bhattacharya, Dipankar, Israr-ul H. Ansari, & Rob Striker. (2009). The flaviviral methyltransferase is a substrate of Casein Kinase 1. Virus Research. 141(1). 101–104. 23 indexed citations
19.
Pfannes, Loretta, et al.. (2007). Selection of an optimal RNA transfection reagent and comparison to electroporation for the delivery of viral RNA. Journal of Virological Methods. 145(1). 14–21. 20 indexed citations
20.
Nilsson, Ulf J., Rob Striker, Scott J. Hultgren, & Göran Magnusson. (1996). PapG adhesin from E. coli J96 recognizes the same saccharide epitope when present on whole bacteria and as isolated protein. Bioorganic & Medicinal Chemistry. 4(11). 1809–1817. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026